Dried Blood Spot Collection Cards Market by Type (Ahlstrom 226, FTA, Whatman 903), Application, Distribution Channel, End-User

Description

List of Tables

The Dried Blood Spot Collection Cards Market was valued at USD 364.56 million in 2023, expected to reach USD 384.31 million in 2024, and is projected to grow at a CAGR of 5.57%, to USD 532.83 million by 2030.

Dried Blood Spot (DBS) Collection Cards offer a simplified, minimally invasive method for collecting and storing blood samples. They utilize filter paper for the absorption and preservation of small quantities of blood, offering logistical ease and cost advantages, especially in remote or resource-limited settings. DBS cards are indispensable in diagnostic screening for infectious diseases, genetic testing, and therapeutic drug monitoring with significant usability in neonatal screening programs. The growing prevalence of chronic and infectious diseases fuels the demand for cost-efficient and reliable diagnostic tools, thus enhancing market growth for DBS collection cards. Moreover, expansion in pharmaceutical and biotechnology sectors, emphasizing personalized medicine, supports their increasing application. Emerging opportunities are tied to technological advancements improved capacity for biobanking, and expansion into newer diagnostic utilities, such as cancer biomarkers and environmental toxin screening. It's critical for businesses to forge partnerships with healthcare and research institutions to ensure market penetration and innovation. However, some major limitations include the challenges in achieving consistent sample quality and variability in analytic results due to card storage conditions. Regulatory adherence is also complex, which could be a barrier for entry into new markets. Research into automating the DBS analysis process and enhancing card material for better sample integrity represents lucrative innovation avenues. Companies may explore the integration of DBS with digital health data platforms, enhancing patient monitoring capabilities. The DBS market is competitive and evolving, driven by innovation and increasing demand for point-of-care diagnostics. Success hinges on addressing existing challenges through continuous R&D in improving accuracy and processing efficiency, and by exploring synergies with rising telehealth services, which can fundamentally reshape the market landscape.

KEY MARKET STATISTICS
Base Year [2023]	USD 364.56 million
Estimated Year [2024]	USD 384.31 million
Forecast Year [2030]	USD 532.83 million
CAGR (%)	5.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dried Blood Spot Collection Cards Market

The Dried Blood Spot Collection Cards Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Growing prevalence of chronic and infectious diseases
- Emerging trend towards at-home sample collection and point-of-care testing
Market Restraints
- Inaccurate result issues with the DBS-based diagnostic tests
Market Opportunities
- Increasing development of advanced assays and analytical techniques
- Growing approval of DBS-based diagnostic tests by regulatory bodies
Market Challenges
- Volume and interference limitations with the DBS-based diagnostic tests

Porter's Five Forces: A Strategic Tool for Navigating the Dried Blood Spot Collection Cards Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dried Blood Spot Collection Cards Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dried Blood Spot Collection Cards Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dried Blood Spot Collection Cards Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dried Blood Spot Collection Cards Market

A detailed market share analysis in the Dried Blood Spot Collection Cards Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dried Blood Spot Collection Cards Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dried Blood Spot Collection Cards Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dried Blood Spot Collection Cards Market

A strategic analysis of the Dried Blood Spot Collection Cards Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dried Blood Spot Collection Cards Market, highlighting leading vendors and their innovative profiles. These include Ahlstrom Oyj, ARCHIMEDlife GmbH, Bioanalytical Systems, Inc. by Inotiv, Inc., BioDynamics LLC, BioIVT LLC by PrecisionMed, LLC, Cambrian Bioworks LLP, Capitainer AB, Centogene N.V., Eastern Business Forms, Inc., F. Hoffmann-La Roche Ltd., Innovatek Medical Inc., Merck KGaA, Monobind Inc., Novilytic LLC, PanoHealth, LLC, PerkinElmer, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., and Trajan Scientific and Medical.

Market Segmentation & Coverage

This research report categorizes the Dried Blood Spot Collection Cards Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Type, market is studied across Ahlstrom 226, FTA, and Whatman 903.
Based on Application, market is studied across Forensic Science, Infectious Disease Testing, Newborn Screening, and Therapeutic Drug Monitoring.
Based on Distribution Channel, market is studied across Offline and Online.
Based on End-User, market is studied across Forensic Labs, Hospitals & Clinics, Pharmaceutical Companies, and Research Laboratories.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-2214614766F5

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Growing prevalence of chronic and infectious diseases
  - 5.1.1.2. Emerging trend towards at-home sample collection and point-of-care testing
- 5.1.2. Restraints
  - 5.1.2.1. Inaccurate result issues with the DBS-based diagnostic tests
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing development of advanced assays and analytical techniques
  - 5.1.3.2. Growing approval of DBS-based diagnostic tests by regulatory bodies
- 5.1.4. Challenges
  - 5.1.4.1. Volume and interference limitations with the DBS-based diagnostic tests
5.2. Market Segmentation Analysis
- 5.2.1. Type: Growing usage of Ahlstrom 226 DBS for longitudinal studies and biobanking
- 5.2.2. Application: High potential of DBS cards for forensic applications as these cards offer stability
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Dried Blood Spot Collection Cards Market, by Type

6.1. Introduction
6.2. Ahlstrom 226
6.3. FTA
6.4. Whatman 903

7. Dried Blood Spot Collection Cards Market, by Application

7.1. Introduction
7.2. Forensic Science
7.3. Infectious Disease Testing
7.4. Newborn Screening
7.5. Therapeutic Drug Monitoring

8. Dried Blood Spot Collection Cards Market, by Distribution Channel

8.1. Introduction
8.2. Offline
8.3. Online

9. Dried Blood Spot Collection Cards Market, by End-User

9.1. Introduction
9.2. Forensic Labs
9.3. Hospitals & Clinics
9.4. Pharmaceutical Companies
9.5. Research Laboratories

10. Americas Dried Blood Spot Collection Cards Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Dried Blood Spot Collection Cards Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Dried Blood Spot Collection Cards Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Swedish company Capitainer secures Euro 6.7 million in Series A funding to enhance dried blood spot card production and expand US and EU sales networks
- 13.3.2. Capitainer's miQro lab Solutions in Rhode Island introduces lead screening with plans to expand into mercury, arsenic, and cadmium testing
- 13.3.3. Innovative blood sampling card by Uppsala University researchers aims to transform disease detection and treatment monitoring
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. Ahlstrom Oyj
2. ARCHIMEDlife GmbH
3. Bioanalytical Systems, Inc. by Inotiv, Inc.
4. BioDynamics LLC
5. BioIVT LLC by PrecisionMed, LLC
6. Cambrian Bioworks LLP
7. Capitainer AB
8. Centogene N.V.
9. Eastern Business Forms, Inc.
10. F. Hoffmann-La Roche Ltd.
11. Innovatek Medical Inc.
12. Merck KGaA
13. Monobind Inc.
14. Novilytic LLC
15. PanoHealth, LLC
16. PerkinElmer, Inc.
17. Shimadzu Corporation
18. Thermo Fisher Scientific Inc.
19. Trajan Scientific and Medical